Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-096640
Filing Date
2024-08-14
Accepted
2024-08-14 06:51:14
Documents
90
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K phvs-20240630.htm   iXBRL 6-K 86040
2 EX-99.1 phvs-ex99_1.htm EX-99.1 41098
3 EX-99.2 phvs-ex99_2.htm EX-99.2 404192
4 EX-99.3 phvs-ex99_3.htm   iXBRL EX-99.3 1082754
5 GRAPHIC img30888848_0.jpg GRAPHIC 35197
6 GRAPHIC img30888848_1.jpg GRAPHIC 631
  Complete submission text file 0000950170-24-096640.txt   6297106

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT phvs-20240630.xsd EX-101.SCH 780362
92 EXTRACTED XBRL INSTANCE DOCUMENT phvs-20240630_htm.xml XML 1305646
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Filer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40010 | Film No.: 241204051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)